Skip to content

A clinical study for evaluating the effects of the combined administration of L-citrulline and L-arginine on blood arginine and NOx levels

A clinical study for evaluating the effects of the combined administration of L-citrulline and L-arginine on blood arginine and NOx levels - A clinical study for evaluating the effects of the combined administration of L-citrulline and L-arginine on blood arginine and NOx levels

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000016647
Enrollment
40
Registered
2015-03-21
Start date
2015-03-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

The administration of the test food containing L-citrulline and L-arginine The administration of the test food containing L-citrulline The administration of the test food containing L-arginine The adm

Sponsors

Soiken Inc.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Healthy male subjects aged from 20 to 49 years old 2) Subjects whose BMI are 25 or over less than 30 kg/m2 3) Subjects who have a briefing of the content of the present study, fully understanding and agreeing to its objective and being able to personally sign a written informed consent

Exclusion criteria

Exclusion criteria: 1) Subjects who regularly take any drugs for cardiovascular or circulatory organs system 2) Subjects who have a history of heart diseases 3) Subjects who have severe liver, kidney, heart, respiratory, endocrine or metabolic diseases 4) Subjects who have a smoking habit 5) Subjects with a heavy alcohol consumption (>60 g/day) 6) Subjects who have an intake of Citrulline or Arginine 7) Subjects who take any drugs for improving circulating 8) Subjects who have the possibility of developing allergic symptoms by the test food 9) Subject having blood sample of 200 ml or more taken (e.g., donated blood) within 1 month, or 400 ml or more within 3 months prior to the start of the present study 10)Subject who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study 11) Subject deemed unsuitable by the investigator

Design outcomes

Primary

MeasureTime frame
Blood arginine and NOx levels

Secondary

MeasureTime frame
Blood cGMP, 8-isoprostane, MDA-LDL, and triglyceride levels

Countries

Japan

Contacts

Public ContactTomohiro Sugino

Soiken Inc. R&D Division

sugino@soiken.com06-6871-8888

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026